DI MARIO, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.575
AS - Asia 14.555
EU - Europa 13.328
SA - Sud America 5.613
AF - Africa 583
OC - Oceania 197
Continente sconosciuto - Info sul continente non disponibili 8
Totale 61.859
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.223
RU - Federazione Russa 6.999
BR - Brasile 4.505
SG - Singapore 3.625
VN - Vietnam 2.879
CN - Cina 2.568
HK - Hong Kong 2.302
IE - Irlanda 1.667
KR - Corea 1.278
IT - Italia 1.008
PL - Polonia 972
SE - Svezia 712
IN - India 578
FR - Francia 534
AR - Argentina 494
DE - Germania 364
ID - Indonesia 299
GB - Regno Unito 277
FI - Finlandia 240
EC - Ecuador 229
AU - Australia 193
CI - Costa d'Avorio 166
BD - Bangladesh 150
CA - Canada 139
IQ - Iraq 138
JP - Giappone 130
ES - Italia 125
MX - Messico 122
UA - Ucraina 122
JO - Giordania 107
CO - Colombia 96
ZA - Sudafrica 91
PY - Paraguay 84
EG - Egitto 75
PK - Pakistan 71
TR - Turchia 68
NL - Olanda 62
CL - Cile 60
VE - Venezuela 54
MA - Marocco 48
AT - Austria 46
UZ - Uzbekistan 40
KE - Kenya 39
CH - Svizzera 38
SA - Arabia Saudita 38
UY - Uruguay 37
PE - Perù 36
TN - Tunisia 35
MU - Mauritius 28
KZ - Kazakistan 27
AZ - Azerbaigian 26
DZ - Algeria 25
PH - Filippine 25
TW - Taiwan 23
JM - Giamaica 21
NG - Nigeria 21
AE - Emirati Arabi Uniti 19
HR - Croazia 18
OM - Oman 18
MY - Malesia 17
DO - Repubblica Dominicana 16
CZ - Repubblica Ceca 15
IR - Iran 15
LB - Libano 15
BG - Bulgaria 14
IL - Israele 14
LT - Lituania 14
AL - Albania 13
HN - Honduras 13
NP - Nepal 13
PT - Portogallo 13
RO - Romania 13
BH - Bahrain 12
BO - Bolivia 12
BJ - Benin 11
GT - Guatemala 11
GE - Georgia 10
RS - Serbia 10
SN - Senegal 10
KW - Kuwait 9
BE - Belgio 7
CR - Costa Rica 7
ET - Etiopia 7
KG - Kirghizistan 7
NI - Nicaragua 7
PS - Palestinian Territory 7
TH - Thailandia 6
XK - ???statistics.table.value.countryCode.XK??? 6
BA - Bosnia-Erzegovina 5
GY - Guiana 5
KH - Cambogia 5
MD - Moldavia 5
AO - Angola 4
BY - Bielorussia 4
CG - Congo 4
DK - Danimarca 4
GR - Grecia 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
PA - Panama 4
Totale 61.790
Salva come PNG Salva come JPEG
Città #
Santa Clara 5.038
Ashburn 3.636
Fairfield 3.231
Singapore 2.665
Hong Kong 1.856
Dublin 1.657
Woodbridge 1.513
Seattle 1.420
Seoul 1.259
Houston 1.232
Cambridge 1.112
Ho Chi Minh City 1.029
Wilmington 965
Warsaw 959
Lawrence 714
Hanoi 579
Medford 540
San Jose 536
Princeton 506
Altamura 489
Moscow 485
Lauterbourg 455
Beijing 450
The Dalles 418
Ann Arbor 378
Mumbai 365
Los Angeles 359
São Paulo 352
Hefei 339
Buffalo 305
Chandler 264
Clifton 235
San Diego 222
Council Bluffs 195
New York 193
Melbourne 169
Helsinki 167
Abidjan 166
Dallas 166
Rio de Janeiro 163
Munich 142
Haiphong 123
Da Nang 119
Redondo Beach 117
Falls Church 115
Florence 110
Jakarta 108
Shanghai 107
Dong Ket 106
Tokyo 99
Boardman 91
Brasília 86
Guangzhou 86
Norwalk 85
Frankfurt am Main 83
Curitiba 78
Barcelona 77
Quito 76
Biên Hòa 74
Boston 73
London 72
Baghdad 68
Porto Alegre 68
Belo Horizonte 67
Hillsboro 65
Kent 65
Guayaquil 63
Hải Dương 61
Orem 57
Thái Bình 57
Campinas 55
Chicago 54
Buenos Aires 52
Toronto 51
Guarulhos 48
Ninh Bình 46
Redwood City 45
Yubileyny 45
Milan 44
Salvador 43
Goiânia 42
Johannesburg 39
Andover 38
Redmond 37
Montevideo 35
Thái Nguyên 35
Phoenix 34
Chennai 33
Montreal 33
Ribeirão Preto 33
Tashkent 33
Turku 33
Brooklyn 32
Can Tho 32
Manaus 32
Nuremberg 32
Nairobi 31
Sumaré 30
Tianjin 30
Rome 29
Totale 40.536
Salva come PNG Salva come JPEG
Nome #
Recanalisation of coronary chronic total occlusions 460
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 360
Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy 287
Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: An underestimated phenomenon 262
Perioperative myocardial infarction in elderly patients with hip fracture. Is there a role for early coronary angiography? 242
Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis 219
Quality control in treating patients with patent foramen ovale: 7-year-experience of the Heart and Brain team of the Careggi University Hospital 216
The DESolve novolimus bioresorbable Scaffold: From bench to bedside 205
Left ventricular outflow tract shape after aortic valve replacement with St. Jude Trifecta prosthesis 204
2014 ESC guidelines on the diagnosis and treatment of aortic diseases 202
Second Generation: Better Also for Covered Stents? 199
Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study 197
Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: A European perspective 196
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 195
A multidisciplinary case report of multiple myeloma with renal and cardiac involvement: a look beyond amyloidosis 194
Theory and practical based approach to chronic total occlusions 193
Lo shock cardiogeno è una malattia rara che necessita di una rete dedicata 187
Prognostic relevance of GRACE risk score in Takotsubo syndrome 184
Risk stratification using the CHA2DS2-VASc score in Takotsubo syndrome: Data from the Takotsubo Italian network 182
Contemporary approach to heavily calcified coronary lesions 182
Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not 180
Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry 180
Peripheral intravascular lithotripsy for transcatheter aortic valve implantation: a multicentre observational study 179
Results of comprehensive cardiovascular diagnostic work-up in HIV positive patients 179
Serial changes in CPET parameters in untreated patients with transthyretin cardiac amyloidosis 176
A Brief History of Coronary Artery Stents 176
Absorb vs. DESolve: An optical coherence tomography comparison of acute mechanical performances 176
P3527Different hemodynamic behavior of remodeling pattern one-year after aortic valve replacement in males and females 176
Percutaneous Trans-septal Mitral Valve-in-Ring Implantation Using a Transcatheter Balloon-Expandable Transcatheter Heart Valve With Elective Intra-Procedural Artero-Venous ECMO in a Patient With Severely Reduced Left Ventricular Ejection Fraction 176
Red flags for the diagnosis of cardiac amyloidosis: Simple suggestions to raise suspicion and achieve earlier diagnosis 175
ECG abnormalities, atrial fibrillation and AV blocks in ATTR VS AL amyloidosis: an electrophysiological natural history 175
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany 175
Calcium: A predictor of interventional treatment failure across all fields of cardiovascular medicine 173
The role for adjunctive image in pre-procedural assessment and peri-procedural management in chronic total occlusion recanalisation 173
2013 ESC guidelines on the management of stable coronary artery disease 170
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents A Propensity-Matched Comparison of the GHOST-EU and XIENCE v USA Registries 170
Why can flu be so deadly? An unusual case of cardiogenic shock 170
64-multislice computed tomography in consecutive patients with suspected or proven coronary artery disease: Initial single center experience 169
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study) 169
Poor right ventricular function is associated with impaired exercise capacity and ventilatory efficiency in transthyretin cardiac amyloid patients 169
Patent foramen ovale closure: how to choose the right device for the right patient 168
Hemodynamic monitoring by pulse contour analysis during trans-catheter aortic valve replacement: A fast and easy method to optimize procedure results 167
Blood lactate predicts survival after percutaneous implantation of extracorporeal life support for refractory cardiac arrest or cardiogenic shock complicating acute coronary syndrome: insights from the CareGem registry 167
A simple step-by-step approach for proficient utilization of the EchoNavigator technology for left atrial appendage occlusion 167
How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study 167
Intravascular imaging to guide lithotripsy in concentric and eccentric calcific coronary lesions 167
Advancements in transcatheter aortic valve implantation: A focused update 166
Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: Insights from the GHOST-EU registry 165
MitraClip Implantation to Treat Early Recurrence of Mitral Regurgitation After Percutaneous Direct Annuloplasty With Cardioband 164
Absorb bioresorbable vascular scaffold: What have we learned after 5 years of clinical experience? 164
Epigallocatechin-3-gallate tolerability and impact on survival in a cohort of patients with transthyretin-related cardiac amyloidosis. A single-center retrospective study 164
A new dedicated stent and delivery system for the treatment of bifurcation lesions: Preliminary experience 162
The V-LAP System for Remote Left Atrial Pressure Monitoring of Patients With Heart Failure: Remote Left Atrial Pressure Monitoring 162
Severe Compression of a Left Main Coronary Stent Implanted Using a Chimney Technique 161
Aortic Stenosis and Cardiac Amyloidosis: PARTNERs in Crime? 159
Biomarkers and Prediction of Prognosis in Transthyretin-Related Cardiac Amyloidosis: Direct Comparison of Two Staging Systems 159
2-Year clinical follow-up from the randomized comparison of biolimus-eluting stents with biodegradable polymer and sirolimus-eluting stents with durable polymer in routine clinical practice 159
Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry 159
Unexpected delayed complete atrioventricular block after Cardioband implantation 159
Bioabsorbable vascular scaffold overexpansion: Insights from in vitro post-expansion experiments 157
Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis 156
Perioperative myocardial infarction in patients with hip fracture: Is there a role for early coronary angiography? 156
Anxious/Depressive Symptoms Alter the Subjective Perception of Heart Failure Severity in Transthyretin Cardiac Amyloidosis 155
New Advances in the Treatment of Severe Coronary Artery Calcifications 155
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 154
TAVI: New trials and registries offer further welcome evidence - U.S. CoreValve, CHOICE, and GARY 154
Coronary collaterals, the natural grafts of CTO lesions - good enough to keep most myocardium alive, unable to prevent ischaemia 154
A cross-sectional imaging study to identify organs at risk of thermal injury during renal artery sympathetic denervation 153
Lithoplasty-assisted transfemoral aortic valve implantation 153
Percutaneous Watchman FLX implantation in a patient with previous mitral valve surgery and large-sized left atrial appendage 153
Bioresorbable vascular scaffold radial expansion and conformation compared to a metallic platform: Insights from in vitro expansion in a coronary artery lesion model 153
Deep sedation vs femoral block anesthesia: beat-by-beat hemodynamic impact on TAVI procedure 153
Improving the net clinical benefit of dual/triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome: discovery and validation of prognostic factors for a tailored therapy 153
Conquering CTO revascularisation: The summit is near with 90% of the ascent behind us 152
Cardiac amyloidosis in patient undergoing TAVR, why we need to think about it 152
Intravascular lithotripsy for calcific coronary and peripheral artery stenoses 151
Biodegradable vascular scaffold: is optimal expansion the key to minimising flow disturbances and risk of adverse events? 151
The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes 151
Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype 151
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry 149
Baseline ECG features and arrhythmic profile in transthyretin versus light chain cardiac amyloidosis 149
Near-infrared spectroscopy predicts events in men and women: Results from the Lipid Rich Plaque study 148
Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry 148
A feasibility and safety study of intracoronary hemodilution during primary coronary angioplasty in order to reduce reperfusion injury in myocardial infarction 148
Appropriateness of percutaneous revascularization of coronary chronic total occlusions: An overview 148
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score 147
The year in cardiology 2016: Coronary interventions 147
Frailty and caregiver relationship quality in older patients diagnosed with transthyretin cardiac amyloidosis 146
A coronary "tunnel": Optical coherence tomography assessment after rotational atherectomy 146
Impact of stent strut design in metallic stents and biodegradable scaffolds 146
A multicentre evaluation of the safety of intracoronary optical coherence tomography 146
Use of thrombectomy devices in primary percutaneous coronary intervention: A systematic review and meta-analysis 146
Left ventricular mass regression after aortic valve replacement: Sex differences or effect of different methods of indexation? 145
ABSORB biodegradable stents versus second-generation metal stents: A comparison study of 100 complex lesions treated under OCT guidance 144
Validation of high temporal resolution spiral phase velocity mapping of temporal patterns of left and right coronary artery blood flow against Doppler guidewire 144
17-Beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease 144
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions 143
Myocardial infarction with nonobstructed coronary arteries following accidental nitrogen inhalation: Diagnosis by cardiac magnetic resonance and coronary computed tomography 143
P3529Left ventricular mass regression after aortic valve replacement: sex differences or effect of different methods of indexation? 143
Perioperative myocardial infarction in patients with hip fracture: Is there a role for early coronary angiography? 143
Totale 17.288
Salva come PNG Salva come JPEG
Categoria #
all - tutte 193.312
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 193.312
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021656 0 0 0 0 0 0 0 0 0 0 402 254
2021/20223.054 45 148 260 98 89 297 72 243 299 144 255 1.104
2022/20234.946 841 1.393 207 118 67 973 766 125 243 60 100 53
2023/20242.270 39 160 554 178 109 331 94 351 60 205 124 65
2024/202517.349 846 2.211 1.365 2.766 4.515 1.742 409 581 1.327 503 481 603
2025/202623.195 1.764 3.336 2.602 5.660 2.234 798 2.236 1.396 1.542 1.192 435 0
Totale 62.505